Relationship between daily and visit-to-visit glycemic in patients with 2 diabetes

被引:15
作者
Tsuchiya, Tami [1 ]
Saisho, Yoshifumi [1 ]
Murakami, Rie [1 ]
Watanabe, Yuusuke [1 ]
Inaishi, Jun [1 ]
Itoh, Hiroshi [1 ]
机构
[1] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan
关键词
Daily glycemic variability; Visit-to-visit glycemic variability; Time in range; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; VARIABILITY; RISK; MORTALITY; ACARBOSE; OUTCOMES; COMPLICATIONS; HYPERGLYCEMIA;
D O I
10.1507/endocrj.EJ20-0012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to explore the relationship between daily glycemic variability (GV) and visit-to-visit glycemic variability (VVV) in patients with type 2 diabetes (T2DM). A total of 156 outpatients with T2DM who had undergone continuous glucose monitoring (CGM) for 5 days were included in this study. Indices of GV, i.e., standard deviation and coefficient of variation (CV) of glucose, mean amplitude of glycemic excursion (MAGE) and mean of the daily differences (MODD) were calculated from the CGM data. VVV was calculated as CV of HbA1c or glycated albumin (GA) from HbA1c or GA measured for 3 years. Relationships among clinical parameters, GV and VVV were evaluated. Age was positively, and BMI and C-peptide index were inversely correlated with GV such as CV glucose and MAGE, while BMI was positively correlated with VVV. Mean glucose rather than GV was correlated with VVV. In contrast, time in range (TIR, 70-180 mg/dL) was correlated with both mean HbA1c or GA and VVV. In conclusion, GV and VVV were differently correlated with clinical parameters and were hardly correlated with each other. TIR was correlated with both mean HbA1c and VVV, suggesting that efforts to achieve optimal TIR are practical strategies to reduce VVV in patients with T2DM.
引用
收藏
页码:877 / 881
页数:5
相关论文
共 26 条
[1]   Glycemic Targets: Standards of Medical Care in Diabetes-2020 [J].
不详 .
DIABETES CARE, 2020, 43 :S66-S76
[2]   Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range [J].
Battelino, Tadej ;
Danne, Thomas ;
Bergenstal, Richard M. ;
Amiel, Stephanie A. ;
Beck, Roy ;
Biester, Torben ;
Bosi, Emanuele ;
Buckingham, Bruce A. ;
Cefalu, William T. ;
Close, Kelly L. ;
Cobelli, Claudio ;
Dassau, Eyal ;
DeVries, J. Hans ;
Donaghue, Kim C. ;
Dovc, Klemen ;
Doyle, Francis J. ;
Garg, Satish ;
Grunberger, George ;
Heller, Simon ;
Heinemann, Lutz ;
Hirsch, Irl B. ;
Hovorka, Roman ;
Jia, Weiping ;
Kordonouri, Olga ;
Kovatchev, Boris ;
Kowalski, Aaron ;
Laffel, Lori ;
Levine, Brian ;
Mayorov, Alexander ;
Mathieu, Chantal ;
Murphy, Helen R. ;
Nimri, Revital ;
Norgaard, Kirsten ;
Parkin, Christopher G. ;
Renard, Eric ;
Rodbard, David ;
Saboo, Banshi ;
Schatz, Desmond ;
Stoner, Keaton ;
Urakami, Tatsuiko ;
Weinzimer, Stuart A. ;
Phillip, Moshe .
DIABETES CARE, 2019, 42 (08) :1593-1603
[3]   Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials [J].
Beck, Roy W. ;
Bergenstal, Richard M. ;
Riddlesworth, Tonya D. ;
Kollman, Craig ;
Li, Zhaomian ;
Brown, Adam S. ;
Close, Kelly L. .
DIABETES CARE, 2019, 42 (03) :400-405
[4]   Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria [J].
Borch-Johnsen, K ;
Neil, A ;
Balkau, B ;
Larsen, S ;
Nissinen, A ;
Pekkanen, J ;
Tuomilehto, J ;
Jousilahti, P ;
Lindstrom, J ;
Pyörälä, M ;
Pyörälä, K ;
Eschwege, E ;
Gallus, G ;
Garancini, MP ;
Bouter, LM ;
Dekker, JM ;
Heine, RJ ;
Nijpels, HG ;
Stehouwer, CDA ;
Feskens, EJM ;
Kromhout, D ;
Peltonen, M ;
Pajak, A ;
Eriksson, J ;
Qiao, Q .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :397-405
[5]   Glycaemic variability in diabetes: clinical and therapeutic implications [J].
Ceriello, Antonio ;
Monnier, Louis ;
Owens, David .
LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (03) :221-230
[6]   Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494
[7]   Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study [J].
Echouffo-Tcheugui, Justin B. ;
Zhao, Songzhu ;
Brock, Guy ;
Matsouaka, Roland A. ;
Kline, David ;
Joseph, Joshua J. .
DIABETES CARE, 2019, 42 (03) :486-493
[8]   Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes [J].
Esposito, Katherine ;
Ciotola, Miryam ;
Carleo, Diego ;
Schisano, Bruno ;
Sardelli, Luigi ;
Di Tommaso, Domenico ;
Misso, Lucio ;
Saccomanno, Franco ;
Ceriello, Antonio ;
Giugliano, Dario .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) :1345-1350
[9]   Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis [J].
Gorst, Catherine ;
Kwok, Chun Shing ;
Aslam, Saadia ;
Buchan, Iain ;
Kontopantelis, Evangelos ;
Myint, Phyo K. ;
Heatlie, Grant ;
Loke, Yoon ;
Rutter, Martin K. ;
Mamas, Mamas A. .
DIABETES CARE, 2015, 38 (12) :2354-2369
[10]   Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies [J].
Hanefeld, M ;
Cagatay, M ;
Petrowitsch, T ;
Neuser, D ;
Petzinna, D ;
Rupp, M .
EUROPEAN HEART JOURNAL, 2004, 25 (01) :10-16